Predictors of clinical improvement in heart failure patients with iron deficiency treated with ferric carboxymaltose-Reference-Cited by-同舟云学术

Predictors of clinical improvement in heart failure patients with iron deficiency treated with ferric carboxymaltose

Published:2021-10 Issue:4 Volume:56 Page:250-257
ISSN:2605-1532
Container-title:REC: CardioClinics
language:en
Short-container-title:REC: CardioClinics

Author:

Esteban-Fernández Alberto,Méndez-Bailón Manuel,Pérez-Serrano Mónica,González-Barja Marcos,Tornero-Molina Fernando,Martín-Sánchez Francisco Javier,Ramírez-Ramos Concepción,Bover-Freire Ramón

Funder

Vifor Pharma Ltd

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Iron deficiency in heart failure with preserved ejection fraction: a systematic review and meta-analysis;Beale;Open Hear,2019

2. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction;Kasner;Int J Cardiol,2013

3. Documento de consenso de la Sociedad Española de Cardiología y la Sociedad Española de Medicina Interna sobre el diagnóstico y tratamiento del déficit de hierro en la insuficiencia cardíaca;Manito;Rev Clin Esp,2017

4. Iron deficiency: prevalence and relation to cardiovascular biomarkers in heart failure outpatients;Schou;Int J Cardiol,2015

5. Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival;Okonko;J Am Coll Cardiol,2011

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ferric carboxymaltose for patients with heart failure in all-range ejection fraction;REC: CardioClinics;2023-07

2. REC: CardioClinics. El empoderamiento de la cardiología clínica;REC: CardioClinics;2022-04